Mme Docteur KAREN DAWIDOWICZ
✨ Profil synthétique
IA · 04/05/2026Mme Docteur Karen Dawidowicz est une rhumatologue exerçant à Saint-Maur-des-Fossés. Ses publications sur PubMed suggèrent une expertise dans les biothérapies non-anti-TNF et la génétique. Elle contribue ainsi à l'avancement des connaissances dans le domaine de la rhumatologie.
Expertises présumées
- Biothérapies non-anti-TNF
- Génétique des maladies rhumatismales
- Traitement des maladies auto-immunes
- Rhumatologie moléculaire
- Thérapies ciblées
- Génétique des maladies inflammatoires
Synthèse automatique à partir des sources publiques (HAL, OpenAlex, theses.fr, ClinicalTrials.gov, FAI²R, ANS). Pas une évaluation clinique. Le médecin peut corriger via son compte.
Diplômes
🎓 DES & spécialité ordinale
- DES Rhumatologie
- Rhumatologie (SM)
🎓 Diplômes
- DE Docteur en médecine
Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.
Bibliographie
Reliability of ultrasound assessment of elementary lesions in psoriatic arthritis and development of a reference dactylitis Atlas
2026ArticleRheumatology
Association of IL-2RA and IL-2RB genes with erosive status in early rheumatoid arthritis patients (ESPOIR and RMP cohorts).
2014ArticleJoint Bone Spine
PTPN22 R620W genotype-phenotype correlation analysis and gene-environment interaction study in early rheumatoid arthritis: results from the ESPOIR cohort.
2011ArticleRheumatology
The Interferon Regulatory Factor 5 Gene Confers Susceptibility to Rheumatoid Arthritis and Influences Its Erosive Phenotype
2011ArticleAnnals of the Rheumatic Diseases
New Rheumatoid Arthritis Genetic Factor and C5 Serum Level
2009ArticleAnnals of the Rheumatic Diseases
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
Localisation
Adresses géocodées via la Base Adresse Nationale (api-adresse.data.gouv.fr). Précision indicative.
Lieux de consultation
CABINET DU DR KAREN DAWIDOWICZ
11 AVENUE VICTOR HUGO, 94100 Saint-Maur-des-Fossés
LibéralGHU APHP HM SITE HENRI MONDOR
51 Avenue MAL DE LATTRE DE TASSIGNY, 94010 Créteil
☎ 0149812111Hospitalier
Tarifs & secteur de conventionnement
Prendre rendez-vous & contact
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Top publications · les plus citées
- 1Hidradenitis suppurativa associated with spondyloarthritis -- results from a multicenter national prospective study
The Journal of rheumatology · 2014
Lire l'abstract Crossref ↓
Objective. To determine the prevalence and characterize the inflammatory musculoskeletal symptoms of hidradenitis suppurativa (HS), a chronic inflammatory disease of skin appendages. Methods. Patients with HS referred to 3 dermatology university hospital centers were systematically screened for peripheral arthritis, dactylitis, inflammatory back pain, or enthesitis. After careful clinical examination, patients were further classified according to clinical and imaging criteria for spondyloarthritis (SpA) using the Amor, European Spondyloarthropathy Study Group (ESSG), and ASsessment in ankylosing spondylitis (ASAS). Results. We screened 640 patients with HS; 184 had musculoskeletal symptoms. In all, 43 (mean age 39.4 yrs, ± 8.3; 80% women) had arthritis, inflammatory back pain, or enthesitis and were investigated further. Signs of HS preceded the onset of articular symptoms in 39 patients (90%), at a mean interval of 3.6 years. A total of 18 (41%), 24 (55%), and 15 (34%) patients fulfilled the Amor, ESSG, and ASAS criteria, respectively, while synovitis, acne, pustolosis, hyperostosis, and osteitis (SAPHO) syndrome was established in 4 patients. The crude prevalence of SpA in all 640 patients with HS was 3.7% by the ESSG criteria. Conclusion. SpA may occur in patients with HS, with the prevalence in this group exceeding that in the general population. The very short time between skin and joint symptom onset in some cases suggests common pathogenic mechanisms underlying HS and SpA.
- 2High levels of anti-cyclic citrullinated peptide autoantibodies are associated with co-occurrence of pulmonary diseases with rheumatoid arthritis
The Journal of rheumatology · 2011
📚 84 citations🎯 RCR 2.78Top 18% NIHLire l'abstract Crossref ↓
Objective. To investigate whether levels of anti-cyclic citrullinated peptide antibodies (anti-CCP2) in patients with rheumatoid arthritis (RA) are associated with the co-occurrence of lung diseases. Methods. A total of 252 RA patients were included in a cross-sectional study. Pulmonary disease was confirmed by high-resolution chest computed tomography scan. Circulating anti-CCP2 were quantified using ELISA. Multivariate logistic regression was conducted to identify independent risk factors for lung disease. Results. Male sex (OR 3.29, 95% CI 1.59–6.80) and high anti-CCP2 levels (OR 1.49, 95% CI 1.25–1.78) were identified as independent risk factors for lung disease in the RA population. Conclusion. High anti-CCP2 levels are associated with lung disease in the RA population.
- 3Phenotype-haplotype correlation of IRF5 in systemic sclerosis: role of 2 haplotypes in disease severity
The Journal of rheumatology · 2010
Lire l'abstract Crossref ↓
Objective.Identification of an association between IRF5 rs2004640 and systemic sclerosis (SSc) has highlighted a key role for type 1 interferon (IFN). Additional functional IRF5 variants have been identified as autoimmune susceptibility factors. Our aim was to investigate whether IRF5 haplotypes confer susceptibility to SSc, and to perform genotype haplotype-phenotype correlation analyses.Methods.We genotyped IRF5 rs377385, rs2004640, and rs10954213 in 1623 individuals of French European Caucasian origin. SSc patient subphenotypes were analyzed according to cutaneous subsets and for SSc-related pulmonary fibrosis.Results.Case-control studies of single markers revealed an association between IRF5 rs3757385, rs2004640, and rs10954213 variants and SSc. We identified an IRF5 risk haplotype “R” (padj = 0.024, OR 1.23, 95% CI 1.07–1.40) and a mirrored protective haplotype “P” (padj = 8.8 × 10−3, OR 0.78, 95% CI 0.68–0.90) for SSc susceptibility. Genotype-phenotype correlation analyses failed to detect any association with a single marker. By contrast, phenotype-haplotype correlation analysis was able to detect intra-cohort association and to discriminate SSc patients with from those without the following clinical traits: “R” and/or “P” haplotypes identified diffuse cutaneous SSc (p = 0.0081) and fibrosing alveolitis (p = 0.018).Conclusion.IRF5 haplotypes are more informative than single markers, suggesting that they could be helpful for risk stratification of SSc patients. Our study provides further evidence of a key role of IRF5 in SSc severity.
Publications scientifiques (12) — classées par pathologie
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Transversal10
▼
Transversal10
▼- Reliability of ultrasound assessment of elementary lesions in psoriatic arthritis and development of a reference dactylitis Atlas
Rheumatology (Oxford, England) · 2026 · Journal Article
Jousse-Joulin S, D'agostino MA, Mouterde G, Naredo E, et al.
- Association of IL-2RA and IL-2RB genes with erosive status in early rheumatoid arthritis patients (ESPOIR and RMP cohorts)
Joint bone spine · 2014 · Journal Article
Ruyssen-Witrand A, Lukas C, Nigon D, Dawidowicz K, et al.
📚 16 cit. - Hidradenitis suppurativa associated with spondyloarthritis -- results from a multicenter national prospective study
The Journal of rheumatology · 2014 · Journal Article
Richette P, Molto A, Viguier M, Dawidowicz K, et al.
📚 90 cit.🎯 RCR 4.18🔬→🩺 Translationnel - Neutrophilic cholangitis in psoriasis vulgaris and psoriatic arthritis
The British journal of dermatology · 2013 · Case Reports
Dieude P, Sbidian E, Viguier M, Zafrani E, et al.
📚 8 cit. - Association study of B-cell marker gene polymorphisms in European Caucasian patients with systemic sclerosis
Clinical and experimental rheumatology · 2011 · Journal Article
Dawidowicz K, Dieudé P, Avouac J, Wipff J, et al.
📚 13 cit.🔬→🩺 Translationnel - PTPN22 R620W genotype-phenotype correlation analysis and gene-environment interaction study in early rheumatoid arthritis: results from the ESPOIR cohort
Rheumatology (Oxford, England) · 2011 · Journal Article
Salliot C, Dawidowicz K, Lukas C, Guedj M, et al.
📚 13 cit.🔬→🩺 Translationnel - High levels of anti-cyclic citrullinated peptide autoantibodies are associated with co-occurrence of pulmonary diseases with rheumatoid arthritis
The Journal of rheumatology · 2011 · Journal Article
Aubart F, Crestani B, Nicaise-Roland P, Tubach F, et al.
📚 84 cit.🎯 RCR 2.78🔬→🩺 Translationnel - The interferon regulatory factor 5 gene confers susceptibility to rheumatoid arthritis and influences its erosive phenotype
Annals of the rheumatic diseases · 2011 · Journal Article
Dawidowicz K, Allanore Y, Guedj M, Pierlot C, et al.
📚 44 cit.🔬→🩺 Translationnel - Phenotype-haplotype correlation of IRF5 in systemic sclerosis: role of 2 haplotypes in disease severity
The Journal of rheumatology · 2010 · Journal Article
Dieude P, Dawidowicz K, Guedj M, Legrain Y, et al.
📚 54 cit.🎯 RCR 1.37 - Unexplained polyarthralgia and celiac disease
Joint bone spine · 2008 · Case Reports
Dawidowicz K, Ea HK, Lahalle S, Qubaja M, et al.
📚 6 cit.
Biothérapies non-anti-TNF1
▼
Biothérapies non-anti-TNF1
▼- 25-hydroxyvitamin D status does not affect the clinical rituximab response in rheumatoid arthritis
Joint bone spine · 2014 · Letter
M'Barek RB, Dupré T, Tubach F, Dieudé P, et al.
📚 1 cit.
Génétique1
▼
Génétique1
▼- New rheumatoid arthritis genetic factor and C5 serum level
Annals of the rheumatic diseases · 2009 · Letter
Mbarek H, Kallel-Sellami M, Zerzri Y, Dawidowicz K, et al.
📚 1 cit.
